About
Akiram Therapeutics develops targeted radioimmunotherapy treatments for metastatic solid tumors by delivering radioactive molecules directly to cancer cells to improve treatment efficacy and minimize damage to healthy tissue.
Explore Akiram Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.